INFORMATION BY CANCER TYPE

Bladder

Tecentriq Approved as First-Line Treatment for Some Patients With Bladder Cancer
BY Jason Broderick
The FDA has granted an accelerated approval to Tecentriq as a frontline treatment for patients with locally advanced or metastatic urothelial carcinoma who are not eligible for cisplatin chemotherapy.
The Future of Immunotherapy for Urothelial Carcinoma Treatment
BY Shannon Connelly
In an interview with CURE, Evan Y. Yu, M.D., discusses the current treatment options for metastatic urothelial carcinoma, the unmet needs that still exist in this space and the possibilities for the future treatment landscape.
Advancing Immunotherapy Impact in Bladder Cancer
BY Gina Columbus
In an interview with CURE, Arlene O. Siefker-Radtke, M.D., discusses immune treatment and the immune landscape for the treatment of patients with urothelial cancers.
My New Life With Cancer
BY Michael Winkel
Immunotherapy Is Moving Forward in Bladder and Other GU Cancers
BY Angelica Welch
Charles Drake, M.D., Ph.D.. is optimistic about immunotherapy as it continues to move toward the frontline setting in GU cancers.
Avelumab Granted Priority Review by the FDA for Metastatic Urothelial Carcinoma
BY Jason M. Broderick
The FDA granted avelumab a priority review to a biologics license application to treat some patients with metastatic urothelial carcinoma, according to the developers of the drug.
Combination Regimen Benefits Genitourinary Cancers
BY Staff Writer
Cabometyx combinations showed activity in patients with GU cancers, according to a preliminary clinical study.
Immunotherapy Duo Trumps Single Agent in Metastatic Bladder Cancer
Patients with metastatic bladder cancer who did not see a benefit on single-agent Opdivo did better when the drug was combined with Yervoy, a recent study showed.
New Treatment Options Offer Hope in Bladder Cancer
BY Danielle Bucco
Checkpoint inhibitors drastically changed the treatment landscape of urothelial carcinoma, and more changes are on the way.
Keytruda Granted Priority Review for Treatment of Urothelial Carcinoma
BY Silas Inman
The FDA granted Keytruda a priority review for the treatment of some patients with urothelial carcinoma.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Bladder CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Bladder Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of bladder cancer.
Gallbladder Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of gallbladder cancer.
x